Product DNN.63.18.040 not checked
Ache Laboratorios Farmaceuticos S.A.
FollowEvery change as it happens, and a Monday email
What this is
- How it works
- How it works isn't classified yet
- Tested for
- Acute Pain
- Main trialPhase 3
- “This study evaluates the safety and efficacy of DNN.63.18.040 compared with Tramal® for the treatment of moderate to severe pain.”In the company’s words, NCT07880392 on ClinicalTrials.gov
Other drugs for Acute Pain
- CombogesicAFT Pharmaceuticals, Ltd. · Phase 3
- S-Ibuprofen Gel 5%Aponia Laboratories, Inc. · Phase 3
- LY4515100Eli Lilly · Phase 2
- SRP-001South Rampart Pharma, Inc. · Phase 2
- GRT7040Grünenthal GmbH · Phase 2
- SBS-147Sparian Biosciences, Inc · Phase 1
Coming up1
- Mar 2027Phase 3 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials1
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 3Not yet recruiting | Mar 2027 | Efficacy and Safety of DNN.63.18.040 for the Treatment of Moderate to Severe Pain |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026